- Morningstar•7 days ago
Across the firm, we are seeing the effects of significant R&D investments, with BD's pipeline the strongest it's been in our history of covering this narrow-moat medical technology company.
- Market Realist•10 months ago
After the release of its 4Q15 earnings results, Becton, Dickinson and Company traded at forward price-to-earnings multiples in the range of 16.6x–17.2x.
Requested symbol wasn't found
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
As of 4:04 PM EDT. Market open.
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|